Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | AMGN | VRTX | REGN | GSK |
| Company | Akcea Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 18.15 | 314.41 | 444.72 | 980.42 | 45.06 |
| High | 18.17 | 315.81 | 447.85 | 987.99 | 45.19 |
| Low | 18.13 | 312.62 | 442.98 | 978.21 | 44.40 |
| Last | 18.17 | 314.54 | 445.87 | 987.27 | 44.59 |
| Change | +0.03 | +2.07 | +0.66 | +4.98 | -0.39 |
| % Change | +0.17% | +0.66% | +0.15% | +0.51% | -0.87% |
| Volume | 815,300 | 1,378,197 | 741,955 | 310,879 | 5,169,795 |
| 20-Day Average Volume | 661,490 | 2,871,585 | 1,089,788 | 453,794 | 3,559,605 |
| Previous Close | 18.14 | 312.47 | 445.21 | 982.29 | 44.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 295.70 | 414.71 | 943.62 | 43.45 |
| 20-Day Raw Stochastic | 70.59% | 85.83% | 96.47% | 98.51% | 74.93% |
| 20-Day Relative Strength | 73.10% | 64.64% | 72.35% | 62.19% | 62.39% |
| Weighted Alpha | -23.90 | +42.40 | +36.13 | +35.48 | +33.02 |
| Today's Opinion | 72% Buy | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 64% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +1.97% since 05/13/24 | +3.71% since 05/13/24 | +1.06% since 05/13/24 | -1.28% since 05/13/24 |
| Low | 18.08 on 10/05/20 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.40 on 05/20/24 |
| High | 18.17 on 10/09/20 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | +16.96% since 04/19/24 | +13.08% since 04/19/24 | +10.09% since 04/19/24 | +12.18% since 04/19/24 |
| Low | 18.05 on 09/21/20 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 18.22 on 09/28/20 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | +10.94% since 02/20/24 | +6.00% since 02/20/24 | +4.27% since 02/20/24 | +6.12% since 02/20/24 |
| Low | 9.81 on 08/05/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 19.65 on 08/31/20 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | +18.54% since 11/20/23 | +24.95% since 11/20/23 | +23.16% since 11/20/23 | +27.00% since 11/20/23 |
| Low | 9.81 on 08/05/20 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 19.65 on 08/31/20 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 101,599 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 488,540,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | 40,770,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 22,380,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -49,580,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.45 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 11/03/20 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.89 | 29.26 | 26.08 | 11.11 |